Low pass whole genome sequencing can be used to calculate the relative proportion of chemotherapy resistant disease in high grade serous ovarian cancer
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-11, Vol.30, p.vii8 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | vii8 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Hockings, H.A. Mossner, M. Lakatos, E. Graham, T. Lockley, M. |
| description | |
| doi_str_mv | 10.1093/annonc/mdz413.030 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz413_030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz413_030</sourcerecordid><originalsourceid>FETCH-LOGICAL-c850-dabbd49ea22eb566314a6ef32466efb60b7f9e1e5dd880b54e5373f7cea961ab3</originalsourceid><addsrcrecordid>eNotkMtOwzAQRbMAiVL4AHbzA2ntOI9miSpeUiU23Udje5IYJXaw01blR_hdXJXVndEdzZFOkjxxtuKsFmu01lm1HvVPzsWKCXaTLFidibQqRH6X3IfwxRgr66xeJL87d4IJQ4BT7waCjqwbCQJ9H8gqYztQaEESHAJpmF1cB3UYcCaYewJPcTRHgsm7yfnZOAuuBdXT6GLvcTrHm2DCjHYGbQJhIDAWetP10HnUF5Z3hwDuiN5EVuQp8g_JbYtDoMf_XCb715f99j3dfb59bJ93qdoULNUopc5rwiwjWZSl4DmW1IosL2PIksmqrYlTofVmw2SRUyEq0VaKsC45SrFM-PWt8i4ET20zeTOiPzecNReZzVVmc5XZRJniDyFwcfE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Low pass whole genome sequencing can be used to calculate the relative proportion of chemotherapy resistant disease in high grade serous ovarian cancer</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Hockings, H.A. ; Mossner, M. ; Lakatos, E. ; Graham, T. ; Lockley, M.</creator><creatorcontrib>Hockings, H.A. ; Mossner, M. ; Lakatos, E. ; Graham, T. ; Lockley, M.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz413.030</identifier><language>eng</language><ispartof>Annals of oncology, 2019-11, Vol.30, p.vii8</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hockings, H.A.</creatorcontrib><creatorcontrib>Mossner, M.</creatorcontrib><creatorcontrib>Lakatos, E.</creatorcontrib><creatorcontrib>Graham, T.</creatorcontrib><creatorcontrib>Lockley, M.</creatorcontrib><title>Low pass whole genome sequencing can be used to calculate the relative proportion of chemotherapy resistant disease in high grade serous ovarian cancer</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkMtOwzAQRbMAiVL4AHbzA2ntOI9miSpeUiU23Udje5IYJXaw01blR_hdXJXVndEdzZFOkjxxtuKsFmu01lm1HvVPzsWKCXaTLFidibQqRH6X3IfwxRgr66xeJL87d4IJQ4BT7waCjqwbCQJ9H8gqYztQaEESHAJpmF1cB3UYcCaYewJPcTRHgsm7yfnZOAuuBdXT6GLvcTrHm2DCjHYGbQJhIDAWetP10HnUF5Z3hwDuiN5EVuQp8g_JbYtDoMf_XCb715f99j3dfb59bJ93qdoULNUopc5rwiwjWZSl4DmW1IosL2PIksmqrYlTofVmw2SRUyEq0VaKsC45SrFM-PWt8i4ET20zeTOiPzecNReZzVVmc5XZRJniDyFwcfE</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Hockings, H.A.</creator><creator>Mossner, M.</creator><creator>Lakatos, E.</creator><creator>Graham, T.</creator><creator>Lockley, M.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201911</creationdate><title>Low pass whole genome sequencing can be used to calculate the relative proportion of chemotherapy resistant disease in high grade serous ovarian cancer</title><author>Hockings, H.A. ; Mossner, M. ; Lakatos, E. ; Graham, T. ; Lockley, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c850-dabbd49ea22eb566314a6ef32466efb60b7f9e1e5dd880b54e5373f7cea961ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hockings, H.A.</creatorcontrib><creatorcontrib>Mossner, M.</creatorcontrib><creatorcontrib>Lakatos, E.</creatorcontrib><creatorcontrib>Graham, T.</creatorcontrib><creatorcontrib>Lockley, M.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hockings, H.A.</au><au>Mossner, M.</au><au>Lakatos, E.</au><au>Graham, T.</au><au>Lockley, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low pass whole genome sequencing can be used to calculate the relative proportion of chemotherapy resistant disease in high grade serous ovarian cancer</atitle><jtitle>Annals of oncology</jtitle><date>2019-11</date><risdate>2019</risdate><volume>30</volume><spage>vii8</spage><pages>vii8-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz413.030</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-11, Vol.30, p.vii8 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz413_030 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Low pass whole genome sequencing can be used to calculate the relative proportion of chemotherapy resistant disease in high grade serous ovarian cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T02%3A25%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20pass%20whole%20genome%20sequencing%20can%20be%20used%20to%20calculate%20the%20relative%20proportion%20of%20chemotherapy%20resistant%20disease%20in%20high%20grade%20serous%20ovarian%20cancer&rft.jtitle=Annals%20of%20oncology&rft.au=Hockings,%20H.A.&rft.date=2019-11&rft.volume=30&rft.spage=vii8&rft.pages=vii8-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz413.030&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz413_030%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |